Back
Rise Gold Vs. CRISPR Therapeutics AG Industry Stock Comparison
Sell
15
RYES
Rise Gold
Last Price:
$0.08
Seasonality Move:
-14.95%
Sell
34
CRSP
CRISPR Therapeutics AG
Last Price:
$38.28
Seasonality Move:
20.1%
Sell
34
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $38.27. The Score for CRSP is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RYES Stock Price Chart
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $38.27The current trend is moderately bullish and CRSP is experiencing slight selling pressure.
RYES Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 48.79 | Sell |
Chaikin Money Flow: | -44340 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.07 - 0.09) | Sell |
Bollinger Bands (100): | (0.07 - 0.09) | Sell |
CRSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.07 | Buy |
Relative Strength Index (14 RSI): | 50.42 | Buy |
Chaikin Money Flow: | -525417 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.9 - 40.02) | Buy |
Bollinger Bands (100): | (37.22 - 46.82) | Sell |
RYES Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.09 | Sell |
20-day SMA: | 0.09 | Sell |
50-day SMA: | 0.07 | Buy |
200-day SMA: | 0.1 | Sell |
8-day EMA: | 0.09 | Sell |
20-day EMA: | 0.08 | Sell |
50-day EMA: | 0.08 | Buy |
200-day EMA: | 0.1 | Sell |
CRSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.43 | Sell |
20-day SMA: | 36.1 | Buy |
50-day SMA: | 40.71 | Sell |
200-day SMA: | 45.82 | Sell |
8-day EMA: | 38.12 | Buy |
20-day EMA: | 34.63 | Buy |
50-day EMA: | 24.01 | Buy |
200-day EMA: | 8.5 | Buy |
Rise Gold Earnings Growth & RYES Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.04 per share, an increase this year of $0.16 per share, and an increase next year of $0.94 per share.
Rise Gold Technical Analysis
Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
CRISPR Therapeutics AG Technical Analysis
Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |